SurgiQ strives to make surgical pathways more effective, less invasive and easier on surgeons, patients and their families, allowing priority based scheduling of both cancer and non-cancer patients, providing a real-time tracking tool with ability for dynamic reporting of entire patient journey from GP referral to post-treatment discharge from the hospital.
We’re creating transparent pathways scalable enough to meet patient’s, hospital’s and payer’s needs. It’s why we align our vision with the interests of our users. It’s why we collect gold-standard clinical evidence and treat ethics as a duty, not a chore.
Surgiq and Barts Health NHS Trust have started a pilot project to improve the way surgical waiting lists are managed, reducing time and effort required to access data.
At Galliera Hospital in Genoa, SurgiQ manages surgical waiting lists in traceable and cooperative manner. The platform allows to share among the surgical team members all relevant information about the pathway in real-time and has improved the process management notably. Patient’s rights are protected by the unique prioritisation algorithm, which allows to schedule activities accordingly with patient’s urgency class and maximum waiting time.
The adoption of SurgiQ brought in several benefits, ranging from a fully paperless and computer based waiting list, to its centralised management to improved guarantees in terms of equity and transparency. All actions on relevant data are tracked, data is audited and the prioritisation system is now a shared tool which helps staff schedule patients for surgery.
SurgiQ has an Information Security Management System certified by RINA in compliance with the standard ISO/IEC 27001:2013 in designing and delivering software solutions in the healthcare market.
"Surgiq s.r.l." (hereinafter, "Surgiq") is an health-tech startup based in Genoa - Italy, Via Venti Settembre 33 and tax number ID IT02395170992.
The site www.surgiq.com (hereinafter, "Website") and its content (text, images, sounds, animations, films, graphics, brands, trademarks, logos, audiovisual content, etc.) are the exclusive property of Surgiq and are protected by current legislation and standards on the protection of trademarks, copyright, etc. (Law of April 22, 1941, no. 633 – hereinafter, "LdA"). In relation to this content, the reproduction, communication to the public, rental and loan, public execution, even partial, and unauthorized distribution by Surgiq are prohibited. Any breaches will be subject to the sanctions specified by Articles. 171, 171-bis, 171-ter, 174-bis and 174-ter of this LdA. The content may be subject to technological protection measures in accordance with Arts. 102-quater and following of the LdA.
The reproduction, on any support, of the materials published in this Website, where expressly permitted, may be carried out, in any case, for exclusively personal use, provided this is done without profit purposes and direct or indirect commercial purposes, in accordance with any technological protection measures.
This Website contains links to other Internet sites, which are not under the control of Surgiq; the publication of these links on the Website does not mean that Surgiq approves or backs these sites or their content; nor is it any form of guarantee or responsibility on the part of Surgiq.
The information on this web site is for your general information only. Information you read on this web site cannot replace the relationship that you have with your health care professional and is not intended to affect that relationship in any way. Surgiq does not practice medicine or provide medical services or advice and the information on this web site should not be considered medical advice. You should always talk to your health care professional for diagnosis and treatment. Health information changes quickly. Therefore, it is always best to confirm information with your health care professional.
The content available on the Website is not tech, health, or economics advice in any form and does not in any way replace the necessary advice and specific tech and health assistance.